NCT07418983 Exercise Effects on Fascia, Low Back Pain, and Function in Scoliosis
| NCT ID | NCT07418983 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Hacettepe University |
| Condition | Scoliosis Idiopathic |
| Study Type | INTERVENTIONAL |
| Enrollment | 30 participants |
| Start Date | 2025-11-02 |
| Primary Completion | 2026-02-16 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.
This trial targets 30 participants in total. It began in 2025-11-02 with a primary completion date of 2026-02-16.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
The use of various muscle energy techniques to address fascial restrictions, in addition to three-dimensional correction within scoliosis-specific exercise approaches, suggests that these exercises may have different effects on thoracolumbar fascia thickness. This may, in turn, lead to varying impacts on low back pain and functional improvement. Therefore, the aim of this study is to investigate the effects of different scoliosis-specific exercise approaches on thoracolumbar fascia thickness, low back pain, and function in individuals with idiopathic lumbar scoliosis and chronic low back pain.
Eligibility Criteria
Inclusion Criteria: * Aged 10-50 years * Diagnosed with idiopathic scoliosis * Presenting a lumbar scoliosis pattern * Cobb angle greater than 15° * Experiencing low back pain for more than 3 months * Pain intensity ≥3 on the Visual Analog Scale (VAS) * Able to read and write Exclusion Criteria: * History of spinal surgery * Received any scoliosis treatment within the last year * Current use of a spinal brace * Use of pain medication * Scoliosis due to non-idiopathic causes (e.g., neurological, congenital) * Presence of neurological, psychological, congenital, or rheumatologic disorders * Any musculoskeletal pathology affecting the spine or trunk
Contact & Investigator
Alev Doğan Özbudak, PT, MSc (PhD Candidate)
PRINCIPAL INVESTIGATOR
Hacettepe University
Frequently Asked Questions
Who can join the NCT07418983 clinical trial?
This trial is open to participants of all sexes, aged 10 Years or older, up to 50 Years, studying Scoliosis Idiopathic. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT07418983 currently recruiting?
Yes, NCT07418983 is actively recruiting participants. Contact the research team at fztalevdogan@gmail.com for enrollment information.
Where is the NCT07418983 trial being conducted?
This trial is being conducted at Ankara, Turkey (Türkiye).
Who is sponsoring the NCT07418983 clinical trial?
NCT07418983 is sponsored by Hacettepe University. The principal investigator is Alev Doğan Özbudak, PT, MSc (PhD Candidate) at Hacettepe University. The trial plans to enroll 30 participants.